Cytokinetics (CYTK) Other Working Capital Changes (2018)

Cytokinetics (CYTK) has reported Other Working Capital Changes for 7 consecutive years, with -$4.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 343.92% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at -$11.8 million (down 637.5% YoY), while the FY2025 annual figure was -$6.2 million, down 360.91% from the prior year.
• Other Working Capital Changes eased to -$4.0 million in Q1 2026 per CYTK's latest filing, from -$3.5 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $49.8 million in Q3 2025 and bottomed at -$51.0 million in Q2 2025.
• Historically, Other Working Capital Changes has averaged -$1.2 million across 5 years, with a median of -$1.8 million in 2023.
• On a YoY basis, Other Working Capital Changes climbed as much as 183.77% in 2025 and fell as far as 1729.41% in 2025.
• Cytokinetics' Other Working Capital Changes stood at -$203000.0 in 2022, then tumbled by 1661.58% to -$3.6 million in 2023, then surged by 106.63% to $237000.0 in 2024, then sank by 1588.61% to -$3.5 million in 2025, then declined by 12.07% to -$4.0 million in 2026.
• Business Quant data shows CYTK's Other Working Capital Changes at -$4.0 million in Q1 2026, -$3.5 million in Q4 2025, and -$2.7 million in Q3 2025.